The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results

References

• Martinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–1372. doi:10.1016/S0140-6736(13)61536-6
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: http://www.ginasthma.org. Accessed July 10, 2019.
   Google Scholar
• Luskin AT, Chipps BE, Rasouliyan L, Miller DP, Haselkorn T, Dorenbaum A. Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol Pract. 2014;2(5):544–552.e541–542. doi:10.1016/j.jaip.2014.02.011
   PubMed Web of Science ®Google Scholar
• Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55(2):208–219. doi:10.1080/02770903.2017.1316394
   PubMed Web of Science ®Google Scholar
• Chipps BE, Zeiger RS, Dorenbaum A, et al. Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Curr Respir Care Rep. 2012;1(4):259–269. doi:10.1007/s13665-012-0025-x
   PubMedGoogle Scholar
• Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19(1):61–67. doi:10.1183/09031936.02.00232001
   PubMed Web of Science ®Google Scholar
• Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med. 2006;100(7):1139–1151. doi:10.1016/j.rmed.2006.03.031
   PubMed Web of Science ®Google Scholar
• Trevor JL, Chipps BE. Severe asthma in primary care: identification and management. Am J Med. 2018;131(5):484–491. doi:10.1016/j.amjmed.2017.12.034
   PubMed Web of Science ®Google Scholar
• Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. doi:10.1186/s40733-016-0029-3
   PubMedGoogle Scholar
• Brown T, Jones T, Gove K, et al. Randomised controlled trials in severe asthma: selection by phenotype or stereotype. Eur Respir J. 2018;52(6):1801444. doi:10.1183/13993003.01444-2018
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Denlinger LC, Fowler SJ, et al. Unmet needs in severe asthma subtyping and precision medicine trials. Bridging clinical and patient perspectives. Am J Respir Crit Care Med. 2019;199(7):823–829. doi:10.1164/rccm.201809-1817PP
   PubMed Web of Science ®Google Scholar
• Chipps BE, Haselkorn T, Paknis B, et al. More than a decade follow-up in patients with severe or difficult-to-treat asthma: the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) II. J Allergy Clin Immunol. 2018;141(5):1590–1597.e1599. doi:10.1016/j.jaci.2017.07.014
   PubMed Web of Science ®Google Scholar
• Chipps BE, Zeiger RS, Borish L, et al. Key findings and clinical implications from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. J Allergy Clin Immunol. 2012;130(2):332–342.e310. doi:10.1016/j.jaci.2012.04.014
   PubMed Web of Science ®Google Scholar
• International Severe Asthma Registry (ISAR). Website. Available from: http://isaregistries.org. Accessed November 14, 2018.
   Google Scholar
• Bulathsinhala L, Eleangovan N, Heaney LG, et al. Development of the International Severe Asthma Registry (ISAR): a modified Delphi study. J Allergy Clin Immunol Pract. 2019;7(2):578–588. doi:10.1016/j.jaip.2018.08.016
   PubMed Web of Science ®Google Scholar
• Hetherington KJ, Heaney LG. Drug therapies in severe asthma – the era of stratified medicine. Clin Med. 2015;15(5):452–456. doi:10.7861/clinmedicine.15-5-452
   Web of Science ®Google Scholar
• Lommatzsch M, Virchow JC. Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl Int. 2014;111(50):847–855. doi:10.3238/arztebl.2014.0847
   PubMed Web of Science ®Google Scholar
• Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi:10.1164/rccm.201804-0682CI
   PubMed Web of Science ®Google Scholar
• Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92(1):32–39. doi:10.1016/S1081-1206(10)61707-3
   PubMed Web of Science ®Google Scholar
• Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–464. doi:10.7326/M15-0288
   PubMed Web of Science ®Google Scholar
• International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals. Available from: http://www.ICMJE.org. Accessed July 31, 2019.
   Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349. doi:10.1016/j.jclinepi.2007.11.008
   PubMed Web of Science ®Google Scholar
• Cloutier MM, Salo PM, Akinbami LJ, et al. Clinician agreement, self-efficacy, and adherence with the guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol Pract. 2018;6(3):886–894.e884. doi:10.1016/j.jaip.2018.01.018
   PubMed Web of Science ®Google Scholar
• American Medical Association. Physician Characteristics and Distribution in the US. American Medical Association; 2015.
   Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi:10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216–2229. doi:10.1016/j.clinthera.2017.09.011
   PubMed Web of Science ®Google Scholar
• Canonica GW, Colombo GL, Bruno GM, et al. Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. World Allergy Organ J. 2019;12(1):100007. doi:10.1016/j.waojou.2018.12.001
   PubMed Web of Science ®Google Scholar